Similar to NK cells, tumor-associated T lymphocytes can recognize and eliminate autologous tumors after ex vivo culture with IL-2 (60, 77, 78), or anti-CD28 and anti-CD3 mAbs (79), despite their inability to kill those targets in situ. Here, IL2 is linked to neoplasm.